Brief: Theriva Biologics Inc - On March 8, Audit Committee Of Co Concluded That Certain Of Co's Financial Statements Should No Longer Be Relied Upon
March 10 (Reuters) - Theriva Biologics Inc TOVX.A :
* THERIVA BIOLOGICS INC - ON MARCH 8, AUDIT COMMITTEE OF CO
CONCLUDED THAT CERTAIN OF CO'S FINANCIAL STATEMENTS SHOULD NO
LONGER BE RELIED UPON
Further company coverage: TOVX.A
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Theriva Biologics
See all newsTheriva Biologics Q2 net loss narrows on lower R&D costs, expenses
Brief: Theriva™ Biologics Announces Upcoming Presentation Of Additional Data From The Virage Phase 2B Clinical Trial Of Vcn-01 In Metastatic Pancreatic Cancer At Aacr 2026 Annual Meeting
Brief: Theriva Biologics Licenses Syn-020 To Rasayana Therapeutics For Multiple Indications
Brief: Theriva Biologics Implements 32% Workforce Reduction - SEC Filing
Brief: Theriva™ Biologics Announces Presentation Of Data From Vcn-01 Retinoblastoma Phase 1 Clinical Trial At Asco 2025